节点文献

复方芎蝎胶囊治疗动脉硬化性血栓性脑梗死100例临床观察

Clinical observation of Fufang Xiongxie capsule on the treatment of arteriosclerotic thrombotic cerebral infarction

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 陈立新张国江贾晓莉姬晓云刘金涛

【Author】 CHEN Lixin,ZHANG Guojiang,JIA Xiaoli,et al.Medical Department,Fengrun District Hospital of Traditional Chinese Medicine,Tangshan City,Hebei Province,Tangshan 064000

【机构】 河北省唐山市丰润区中医院内科河北省唐山市中医医院内科

【摘要】 目的观察复方芎蝎胶囊治疗动脉硬化性血栓性脑梗塞(恢复期)的临床疗效。方法将300例患者随机分为3组,治疗组100例,予复方芎蝎胶囊口服;对照1组100例,予血塞通软胶囊口服;对照2组100例,予维脑路通配合肠溶阿斯匹林口服。3组均4周为1个疗程,1个疗程统计临床疗效及神经功能缺损改善情况。结果治疗组临床疗效总有效率94%,对照1组总有效率82%,对照2组总有效率78%,治疗组总有效率与对照1组、对照2组比较差异有统计学意义(P<0.05),治疗组优于对照1组、对照2组;治疗组治疗后临床神经功能缺损程度评分与对照1组、对照2组比较差异均有统计学意义(P<0.05),治疗组优于对照1组及对照2组。结论复方芎蝎胶囊治疗动脉硬化性血栓性脑梗塞(恢复期)疗效确切。

【Abstract】 Objective To observe the clinical effect of atherothrombotic brain infarction (ABI) during the period of recover treated by Fuang Xiongxie capsule.Methods 300 cases of ABI were divided into 3 groups in random.Cases in treatment group (n=100) were treated by Fuang Xiongxie capsule.Patients in control group One (n=100) were treated by Xushuantong capsule.Cases in control group Two (n=100) were treated by Troxerutin,Aspirin enteric-coated tablets PO in evening.The course of treatment in 3 groups was 4 weeks.And the curative effect and the improvement of neurologic impairment were observed.Results compared the curative effect of 3 groups,The total effective rate in treatment group,control group One and control group Two were 94%,82% and 78%,respectively.There was significant difference between three groups on the total effective rate (P<0.05).There were significance between three groups on the improvement of neurologic impairment after treatment (P<0.05).Conclusion Prescription Xiongxie capsule has a definite effect on the treatment of ABI (period of recover).

【基金】 2007年河北省科学技术研究与发展指导计划项目(第一批)(编号:07276804)
  • 【文献出处】 河北中医 ,Hebei Journal of Traditional Chinese Medicine , 编辑部邮箱 ,2010年03期
  • 【分类号】R277.7
  • 【被引频次】6
  • 【下载频次】66
节点文献中: 

本文链接的文献网络图示:

本文的引文网络